Back
Kazia Therapeutics Quote, Financials, Valuation and Earnings
"This Changes Everything" - Trump Hands Millions Massive IRS Gift
Learn More Here
Buy
64
KZIA
Kazia Therapeutics
Last Price:
5.85
Seasonality Move:
12.5%
7 Day Trial
ALL ACCESS PASS
$
7
America's enemies are regrouping & it may sucker punch your savings
Click here to learn more.Kazia Therapeutics Price Quote
$5.85
+0.24 (+4.28%)
(Updated: November 21, 2024 at 10:25 AM ET)
Kazia Therapeutics Key Stats
Buy
64
Kazia Therapeutics (KZIA)
is a Buy
Day range:
$5.50 - $6.01
52-week range:
$1.87 - $15.80
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0%
Volume:
41.1K
Avg. volume:
171.8K
1-year change:
-27.3%
Market cap:
$16.9M
Revenue:
$1.5M
EPS:
$-6.67
How Much Does Kazia Therapeutics Make?
Data Unavailable
Is Kazia Therapeutics Growing As A Company?
-
What Is Kazia Therapeutics's Growth Rate Quarterly?
Quarterly YoY revenue growth is -0.96% -
What Is Kazia Therapeutics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Kazia Therapeutics Stock Price Performance
-
Did Kazia Therapeutics Stock Go Up Last Month?
Kazia Therapeutics share price went up by 11.66% last month -
Did KZIA's Share Price Rise Over The Last Year?
KZIA share price fell by -27.3% over the past 1 year
What Is Kazia Therapeutics 52-Week High & Low?
-
What Is Kazia Therapeutics’s 52-Week High Share Price?
Kazia Therapeutics has traded as high as $15.80 over the past 52 weeks -
What Is Kazia Therapeutics’s 52-Week Low Share Price?
Kazia Therapeutics has traded as low as $1.87 over the past 52 weeks
Kazia Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Kazia Therapeutics?
-
How Much Debt Does Kazia Therapeutics Have?
Total long term debt quarterly is $423.8K -
How Much Cash Does Kazia Therapeutics Have?
Cash and short term investments quarterly total is $1.1M -
What Is Kazia Therapeutics’s Book Value Per Share?
Book value per share is -2.01
Is Kazia Therapeutics Cash Flow Positive?
-
What Is KZIA Cash Flow From Operations?
Cash flow from operations (TTM) is -$6.3M -
What Is Kazia Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $3.9M -
What Is Kazia Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is $0
Kazia Therapeutics Return On Invested Capital
-
Is Management Doing A Good Job?
KZIA return on invested capital is -784.09% -
What Is Kazia Therapeutics Return On Assets?
ROA measures how assets are converting to revenues and is -106.28% -
What Is KZIA Return On Equity?
ROE is a measure of profitability and is -1083.16%
Kazia Therapeutics Earnings Date & Stock Price
-
What Is Kazia Therapeutics's Stock Price Today?
A single share of KZIA can be purchased today for 5.61 -
What Is Kazia Therapeutics’s Stock Symbol?
Kazia Therapeutics trades on the nasdaq under the ticker symbol: KZIA -
When Is Kazia Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Kazia Therapeutics is scheduled on February 28, 2025 -
When Is KZIA's next ex-dividend date?
Kazia Therapeutics's next ex-dividend date is May 26, 2020 -
How To Buy Kazia Therapeutics Stock?
You can buy Kazia Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Kazia Therapeutics Competitors
-
Who Are Kazia Therapeutics's Competitors?
Below is a list of companies who compete with Kazia Therapeutics or are related in some way:
Kazia Therapeutics Dividend Yield
-
What Is KZIA Dividend Yield?
Kazia Therapeutics’s dividend yield currently is 0% -
What Is Kazia Therapeutics’s Payout Ratio?
Kazia Therapeutics’s payout ratio is 0% -
When Did Kazia Therapeutics Last Pay A Dividend?
The latest dividend pay date is November 21, 2024 -
What Is Kazia Therapeutics’s Dividend Per Share?
Kazia Therapeutics pays a dividend of $0.00 per share
Kazia Therapeutics Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 0% |
| Revenue: | -95.91% | 0% |
Analyst Recommendations
| Buy Recommendations: | 0 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 19.98 |
| Upside from Last Price: | 256.2% |